Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Decker

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Virology|June 29, 2004
Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction siteMarintha L Heil, Julie M Decker, Jeffrey N Sfakianos, et al.
Journal of Virology|December 21, 2007
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody responseElin S Gray, Penny L Moore, Frederic Bibollet-Ruche, et al.
Virology|September 15, 2009
Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytesJulie M Decker, Kenneth P Zammit, Juliet L Easlick, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapyXiping Wei, Julie M Decker, Hongmei Liu, et al.
The Journal of Clinical Investigation|April 17, 2012
Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptationFrederic Bibollet-Ruche, Anke Heigele, Brandon F Keele, et al.
Journal of Molecular Biology|July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoproteinFrançois Stricher, Chih-chin Huang, Anne Descours, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Journal of Virology|March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stockMichael Lopker, Juliet Easlick, Sarah Sterrett, et al.
Journal of Virology|November 21, 2008
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasmaKatie L Davis, Frederic Bibollet-Ruche, Hui Li, et al.
Nature Medicine|February 1, 2002
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cellsGang Meng, Xiping Wei, Xiaoyun Wu, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Virology|June 29, 2004
Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction siteMarintha L Heil, Julie M Decker, Jeffrey N Sfakianos, et al.
Journal of Virology|December 21, 2007
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody responseElin S Gray, Penny L Moore, Frederic Bibollet-Ruche, et al.
Virology|September 15, 2009
Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytesJulie M Decker, Kenneth P Zammit, Juliet L Easlick, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapyXiping Wei, Julie M Decker, Hongmei Liu, et al.
The Journal of Clinical Investigation|April 17, 2012
Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptationFrederic Bibollet-Ruche, Anke Heigele, Brandon F Keele, et al.
Journal of Molecular Biology|July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoproteinFrançois Stricher, Chih-chin Huang, Anne Descours, et al.
Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Journal of Virology|March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stockMichael Lopker, Juliet Easlick, Sarah Sterrett, et al.
Journal of Virology|November 21, 2008
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasmaKatie L Davis, Frederic Bibollet-Ruche, Hui Li, et al.
Nature Medicine|February 1, 2002
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cellsGang Meng, Xiping Wei, Xiaoyun Wu, et al.
Pageof 5